Table 2.
Anthropometric and serum variables from control and fish oil supplemented women before and after the 8-week weight loss treatment.
| Control | Fish oil | Interaction | Weight loss treatment | Oral suppl. | |||
|---|---|---|---|---|---|---|---|
| Baseline | Endpoint | Baseline | Endpoint | ||||
| Anthropometric | |||||||
| Age, years | 35.1 ± 5.5 | — | 32.4 ± 5.0 | — | |||
| Height, m | 1.65 ± 0.06 | — | 1.61 ± 0.05 | — | |||
| Weight, kg | 82.9 ± 2.3 | 78.7 ± 3.0 | 78.8 ± 5.2 | 73.6 ± 5.6 | ns. | P < 0.05 | ns. |
| BMI, kg/m2 | 30.7 ± 2.0 | 29.1 ± 2.6 | 30.5 ± 1.7 | 28.4 ± 1.8 | ns. | P < 0.05 | ns. |
| SBP, mmHg | 120.6 ± 9.6 | 121.8 ± 8.3 | 115.4 ± 9.5 | 113.1 ± 5.7 | ns. | ns. | ns. |
| DBP, mmHg | 67.2 ± 4.1 | 68.4 ± 2.9 | 72.1 ± 6.5 | 68.9 ± 5.6 | ns. | ns. | ns. |
| Serum | |||||||
| Glucose, mg/dL | 86.9 ± 4.6 | 85.1 ± 3.2 | 88.1 ± 6.0 | 90.6 ± 9.7 | ns. | ns. | ns. |
| Insulin, mU/L | 8.4 ± 4.0 | 8.2 ± 4.0 | 12.4 ± 6.7 | 8.3 ± 3.3 | ns. | ns. | ns. |
| HOMA index | 1.8 ± 0.9 | 1.7 ± 0.7 | 2.7 ± 1.5 | 1.8 ± 0.7 | ns. | ns. | ns. |
| Leptin, μg/mL | 37.6 ± 10.7 | 25.4 ± 8.4 | 30.6 ± 14.5 | 18.5 ± 8.0 | ns. | P < 0.05 | ns. |
| Total cholesterol, mg/dL | 214.9 ± 49.0 | 200.1 ± 44.9 | 197.4 ± 46.5 | 185.4 ± 35.1 | ns. | ns. | ns. |
| LDL cholesterol, mg/dL | 132.5 ± 30.9 | 124.8 ± 26.9 | 114.0 ± 40.6 | 114.5 ± 29.7 | ns. | ns. | ns. |
| HDL cholesterol, mg/dL | 65.2 ± 21.2 | 58.2 ± 24.7 | 57.0 ± 11.0 | 52.7 ± 8.8 | ns. | ns. | ns. |
| Triglycerides, mg/dL | 85.9 ± 48.7 | 85.8 ± 26.1 | 131.9 ± 75.0 | 88.1 ± 35.3 | ns. | ns. | ns. |
Data represent mean ± SD (control n = 5; fish oil group n = 7). Differences within and between subjects were determined by a general linear model with repeated measures. ns.: not significant; SBP: systolic blood pressure; DBP: diastolic blood pressure; HOMA: homeostasis model assessment; Oral suppl.: effect of the oral supplementation of fish oil.